Esta web utiliza cookies técnicas, de personalización y de análisis, propias y de terceros, para anónimamente facilitarle la navegación y analizar estadísticas del uso de la web. Obtener más información
Resultados de búsqueda
-
S&P Indices and the Indexing Business in 2012
Viceira, Luis M.; Wagonfeld, Alison BerkleyCaso HBS-213049-EFinanzasIn June 2012, Standard & Poor's Indices is finalizing a deal with the CME Group, the largest global exchange for futures and options and majority owner of Dow Jones Indexes, to combine their respective indices business into a new joint venture called S&P Dow Jones Indices. This case discusses the index provider business model through the lenses of this transaction: sources of revenue and profitability, business valuation, uses of indexes in the m...Desde 8,20 €
-
Sustainable Investing at J.P. Morgan Private Bank
Fleiss, Sara L.; Viceira, Luis M.Caso HBS-220016-EFinanzasThis case features Monica Issar, then Global Head of J.P. Morgan Endowments & Foundations Group in the Private Bank. In just five years, she and J.P. Morgan have grown the Outsourced Chief Investment Officer (OCIO) business from $5 billion in AUM from primarily family foundations to $30 billion AUM of institutional capital. Increasingly, clients are requesting guidelines that reflect not only their risk and return preferences, but also their soci...Desde 8,20 €
-
Halftime for Heidelberg
Spar, Debora L.Caso HBS-720021-EDirección estratégicaThe case follows President Rob Huntington as he seeks to find a viable way forward for Heidelberg University. Located in Tiffin, Ohio, Heidelberg is a small, private, four-year university. As with many similar institutions of higher education, it currently faces a daunting and mounting set of challenges, most of which stem from financial and demographic changes that are far beyond its control. During Huntington's eleven-year tenure, the universi...Desde 8,20 €
-
The Private Company Council
Ramanna, Karthik; Viceira, Luis M.Caso HBS-113045-EContabilidad y controlFinancial Accounting Foundation chairman Jack Brennan is under pressure from private-company interests to set up a new body-the Private Company Council-to determine separate GAAP for private companies. PCC advocates-including the US Chamber of Commerce-argue that traditional US GAAP has too many disclosure and fair-value requirements that impose very high compliance costs on private companies. But there are influential players-including the Big F...Desde 8,20 €
-
Afrigen Biologics: Vaccines for the Global South, Teaching Note
Spar, Debora L.; Comeau, JuliaNota del Instructor HBS-323098-EEconomíaTeaching note to case 323030Desde 0,00 €
-
Nextel Peru: Emerging Market Cost of Capital, Teaching Note
Viceira, Luis M.; Heilprin, Joel L.Nota del Instructor HBS-916517-EFinanzasTeaching note for case 916516.Desde 0,00 €
-
The Social Purpose of the Firm
Spar, Debora L.; Comeau, JuliaCaso HBS-323051-EConocimiento y comunicaciónThe Social Purpose of the Firm (SPF) is a short module designed to explore how, and under what circumstances, business leaders can harness the power of capitalism and markets to "make a difference in the world" - that is, to address a significant societal problem as a commercial endeavor. This Module Note summarizes the cases and themes discussed in SPF. Together, the cases are designed to study entrepreneurs and business leaders who are tackling...Desde 8,20 €
-
Extend Fertility: Conceiving the Market for Egg Preservation, Teaching Note
Spar, Debora L.; Hull, OliviaNota del Instructor HBS-720002-EDirección estratégicaTeaching note for case 719019.Desde 0,00 €
-
Afrigen Biologics: Vaccines for the Global South
Spar, Debora L.; Comeau, JuliaCaso HBS-323030-EEconomíaThe majority of vaccines used on the continent of Africa (99%) are produced offshore. This makes African nations reliant on the West for major health care needs, a problem which was exacerbated by the COVID-19 pandemic. Afrigen Biologics (in partnership with the WHO) is seeking to lessen this disparity by putting vaccine production in the hands of South Africans and other low- and middle-income countries. Afrigen Biologics is the first in a plann...Desde 8,20 €
-
Trian Partners and DuPont (B)
Viceira, Luis M.; Kaul, Dhruva; Lee, PeterCaso HBS-216078-EFinanzasDesde 5,74 €